 |
bromodomain and Extra-Terminal (BET) Inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2017-04-05 00:00:00 |
| Sponsor | FORMA Therapeutics, Inc.;500 Arsenal Street, Suite 100;Watertown, Massachusetts, 02472 |
